Literature DB >> 21980257

Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens.

A J Dawson1, J McGowan-Jordan, J Chernos, J Xu, J Lavoie, J C Wang, M Steinraths, S Shetty.   

Abstract

The Canadian College of Medical Geneticists (ccmg) is a national organization of medical and laboratory geneticists. The mission of the ccmg is to establish and maintain high-quality professional and ethical standards for medical genetics services in Canada and to help to ensure that service of the highest quality is delivered to the Canadian public.Cancer cytogenetics is one of the sections of practice of the ccmg. The ccmg Cytogenetic Committee has, therefore, put forward guidelines to provide oncologists and ccmg cytogeneticists with a comprehensive review of the cytogenetic diagnostic tests that are recommended as a minimum standard of care for tumours of hematopoietic and lymphoid tissues and for tumours of soft tissue and bone. The guidelines were approved by the ccmg board of directors in June 2010.

Entities:  

Keywords:  Cytogenetics; cancer; hematopoietic; lymphoid; tumours

Year:  2011        PMID: 21980257      PMCID: PMC3185907          DOI: 10.3747/co.v18i5.775

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  5 in total

1.  A multicenter investigation with D-FISH BCR/ABL1 probes.

Authors:  G Dewald; R Stallard; A Alsaadi; S Arnold; R Blough; T M Ceperich; B Rafael Elejalde; J Fink; J V Higgins; R R Higgins; G A Hoeltge; W T Hsu; E B Johnson; D Kronberger; D J McCorquodale; L F Meisner; M A Micale; L Oseth; J S Payne; S Schwartz; S Sheldon; A Sophian; P Storto; P Van Tuinen; G D Wenger; A Wiktor; L A Willis; J F Yung; J Zenger-Hain
Journal:  Cancer Genet Cytogenet       Date:  2000-01-15

2.  The proportion of clonal divisions varies in different hematologic malignancies. The United Kingdom Cancer Cytogenetics Group (UKCCG) [corrected].

Authors:  G J Swansbury
Journal:  Cancer Genet Cytogenet       Date:  1998-07-15

3.  A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes.

Authors:  G Dewald; R Stallard; A Al Saadi; S Arnold; P I Bader; R Blough; K Chen; B R Elejalde; C J Harris; R R Higgins; G A Hoeltge; W T Hsu; V Kubic; D J McCorquodale; M A Micale; J W Moore; R M Phillips; S Scheib-Wixted; S Schwartz; S Siembieda; K Strole; P VanTuinen; G H Vance; A Wiktor; A Zinsmeister
Journal:  Am J Med Genet       Date:  1998-04-01

4.  Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation.

Authors:  G W Dewald; C R Schad; E R Christensen; M E Law; A R Zinsmeister; P G Stalboerger; S M Jalal; R C Ash; R B Jenkins
Journal:  Bone Marrow Transplant       Date:  1993-08       Impact factor: 5.483

5.  Normal cytogenetic values for bone marrow based on studies of bone marrow transplant donors.

Authors:  D G Kuffel; C G Schultz; R C Ash; G W Dewald
Journal:  Cancer Genet Cytogenet       Date:  1991-08
  5 in total
  3 in total

1.  A graphical, interactive and GPU-enabled workflow to process long-read sequencing data.

Authors:  Shishir Reddy; Ling-Hong Hung; Olga Sala-Torra; Jerald P Radich; Cecilia Cs Yeung; Ka Yee Yeung
Journal:  BMC Genomics       Date:  2021-08-23       Impact factor: 4.547

2.  Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.

Authors:  Carmel Jacobs; Ian D Graham; Julie Makarski; Michaël Chassé; Dean Fergusson; Brian Hutton; Mark Clemons
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

3.  Preimplantation genetic testing for aneuploidy: The management of mosaic embryos.

Authors:  Eun Jeong Yu; Min Jee Kim; Eun A Park; Inn Soo Kang
Journal:  Clin Exp Reprod Med       Date:  2022-08-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.